Moreover, as the decrease in NADPH-oxidase activity results in reduced ROS levels emission (Adams et al., 2005) more studies are also needed to verify if the decrease in ROS production induced by chronic PE has clinical significance in vitiligo patients. Here, FMO5 is linked to vitiligo.